The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Porcine Epidemic Diarrhea Vaccines Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The porcine epidemic diarrhea vaccines market has experienced substantial growth in recent years. It is projected to expand from $1.8 billion in 2025 to $1.94 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. This historical growth can be linked to recurring outbreaks of porcine epidemic diarrhea, significant mortality rates among newborn piglets, financial setbacks for the swine industry, the constrained efficacy of non-vaccine disease management methods, and a heightened dependence on veterinary-guided disease prevention.
The porcine epidemic diarrhea vaccines market is projected to experience substantial growth in the coming years. It is anticipated to reach $2.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This expansion during the forecast period can be attributed to the rise of intensive pig farming practices, increasing global demand for pork products, a heightened awareness of herd immunity benefits, the expansion of organized hog production farms, and supportive government animal health initiatives. Major trends in the forecast period include the increasing adoption of preventive vaccination in swine health management, a growing preference for live vaccines in endemic regions, a rising focus on early immunization of piglets, the expansion of vaccination programs in commercial hog farms, and a greater emphasis on biosecurity and disease control protocols.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
Which Core Factors Are Supporting The Expansion Of The Porcine Epidemic Diarrhea Vaccines Market?
Future expansion of the porcine epidemic diarrhea vaccine market is anticipated due to the rising trend in pig farming. This practice encompasses the cultivation of domestic pigs for various purposes, including meat production, breeding activities, animal rearing, overseeing livestock from birth until they reach market weight, and the subsequent production and commercialization of pork items. Several factors contribute to the growth of pig farming, such as increasing worldwide demand for pork, progress in breeding techniques and herd management, technological enhancements in swine production, and the expansion of commercial pork sales channels. Porcine epidemic diarrhea (PED) vaccines are vital in pig farming, as they aid in preventing and controlling disease outbreaks; these vaccines are typically given during the gestation period of sows to confer passive immunity to their offspring. For example, the U.S. Department of Agriculture, a US-based government agency, reported in April 2024 a projection of U.S. pork production reaching 12.7 million metric tons, indicating a rise in swine output that fosters ongoing growth in the pig farming industry. Consequently, the expansion of pig farming is a key factor propelling the development of the porcine epidemic diarrhea vaccine market.
Which Segment Divisions Form The Structure Of The Porcine Epidemic Diarrhea Vaccines Market?
The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
What Trends Are Affecting The Porcine Epidemic Diarrhea Vaccines Market Dynamics?
Leading companies operating in the Porcine Epidemic Diarrhea (PED) vaccines market are concentrating on developing innovative solutions, such as next-generation inactivated and recombinant vaccines, to enhance immunity and provide broader protection against emerging PEDV strains. These advanced vaccines, whether inactivated or recombinant, employ either killed viruses or engineered viral proteins to trigger strong, targeted immunity, while also improving safety and defense against evolving disease strains. For instance, in August 2024, Zoetis Inc., a US-based animal health company, was awarded a grant for Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and also received a conditional license from the U.S. Department of Agriculture (USDA) for a vaccine designed to combat PEDV in pigs. These actions reinforce Zoetis’s contribution to developing advanced swine health solutions by supporting further research, boosting vaccine effectiveness, and expanding protection against emerging PEDV strains.
Who Are The Companies Shaping The Porcine Epidemic Diarrhea Vaccines Market Landscape?
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines
Access The Complete Porcine Epidemic Diarrhea Vaccines Market Report:
Which Region Accounts For The Highest Share Of The Porcine Epidemic Diarrhea Vaccines Market?
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Porcine Epidemic Diarrhea Vaccines Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
Browse Through More Reports Similar to the Global Porcine Epidemic Diarrhea Vaccines Market 2026, By The Business Research Company
Porcine Epidemic Diarrhea Vaccines Market Report 2026
Porcine Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
Swine Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model